
is even less deﬁned than for de novo mesenteric artery lesions. The basic management principles for the de novo
asymptomatic lesions are likely appropriate, although a
lower threshold for remedial intervention may be justiﬁed
given the prior symptomatology and the potential rate of
recurrent symptoms, particularly since the remedial endovascular interventions are relatively safe.

FUTURE RESEARCH
Deﬁne the natural history of symptomatic recurrent
stenosis after both end